InsidersTradesSigma
Follow the BioInvent International Aktiebolag share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, BioInvent International Aktiebolag has published 2 insider filings. Market capitalisation: €1.6bn. The latest transaction was filed on 29 May 2026 (Purchase). Among the most active insiders: Stefan Eriksson. The full history is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
BioInvent International Aktiebolag 是一家瑞典生物制药公司，专注于开发癌症治疗方法。该公司在斯德哥尔摩证券交易所上市，股票代码为 XSTO。